Evidence map›Paper›PMID 35836493›Full record

ArticleNMC case report journal2022

Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after COVID-19.

Yu Nomura, Masato Naraoka, Nozomi Fujiwara, Shouhei Kinoshita, Keita Yanagiya, Takao Sasaki, Ryouta Watanabe, Kouta Ueno, Norihito Shimamura

Open access · diamondAbstract readCase Reports
In one paragraph

Article in NMC case report journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yu NomuraDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Masato NaraokaDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Nozomi FujiwaraDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Shouhei KinoshitaDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Keita YanagiyaDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Takao SasakiDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Ryouta WatanabeDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Kouta UenoDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Norihito ShimamuraDepartment of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Hirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic subdural hematoma (CSDH) typically develops in the supratentorial region in elderly patients. We treated a case of unilateral supratentorial and bilateral infratentorial CSDH, whereby the patient had a coronavirus disease 2019 (COVID-19) infection combined with disseminated intravascular coagulation 2 months earlier. The patient had not experienced any head trauma before the onset of the CSDH. The postoperative course was uneventful, and the patient experienced no neurological deficit. We propose that we should be aware not only of acute ischemic or hemorrhagic diseases after COVID-19 infection but also of chronic subdural hematoma caused by coagulopathy after a COVID-19 infection.

Indexed as

anticoagulation therapyCOVID-19disseminated intravascular coagulationsupratentorial and infratentorial chronic subdural hematoma

Identifiers

PMID35836493
PMCPMC9239695
OpenAlexW4282930050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.